The World of Health & Medicine News

Tuberculosis rates fall for the first time since COVID-19 pandemic, WHO report

Tuberculosis rates fall for the first time since COVID-19 pandemic, WHO report

Global tuberculosis illness rates fell about 2% from 2023 to 2024, according to a World Health Organization report,​ after rising for three consecutive years due to COVID-related disruptions to ‌diagnosis and treatment.

Most indicators of the disease burden were moving in the right direction after setbacks during the pandemic,‌ but progress still fell short of 2030 targets, the agency said.

WHO adopted the “End TB Strategy” in 2014 and 2015 that included targets for 2020, 2025, 2030 and 2035 to sharply cut tuberculosis incidence, deaths and patient costs.

In 2024, 1.23 ⁠million people died from TB, ‌a fall of 29% from 2015. The health agency said this was far from its goals of a 75% reduction by ‍2025 and a 90% lowering by 2030.

“(A) major obstacle is global funding for TB, which has stagnated since 2020,” said Tereza Kasaeva, Director of WHO’s division ​for tuberculosis, HIV and related infections.

“Modeling studies have already warned that long-‌term cuts to international donor funding could result in up to 2 million additional deaths and 10 million people falling ill with TB between 2025 and 2035,” Kasaeva said.

The United States withdrew from the WHO in January, citing alleged mismanagement, creating a multi-billion-dollar gap in the agency’s 2026–27 budget and forcing a 21% ⁠cut in proposed spending.

Critical international aid, particularly from ​the U.S. Agency for International Development, ​had helped avert about 3.65 million deaths from the deadly disease last year alone, according to WHO.

“With the shocking cuts in international aid ‍we are seeing this ⁠year, the children will be hit hardest as they already face the largest gaps in accessing TB care,” global medical charity Médecins Sans Frontières said ⁠in a statement.

spot_img

Explore more

spot_img

This Easy Daily Habit Could Hold Back Alzheimer’s for Years

This Easy Daily Habit Could Hold Back Alzheimer’s for Years A new study found that walking just a few thousand steps daily can significantly delay Alzheimer’s symptoms. Participants...

Alkermes’ narcolepsy drug shows promise in mid-stage trial

Alkermes’ narcolepsy drug shows promise in mid-stage trial -Alkermes’ experimental drug significantly improved wakefulness and reduced excessive sleepiness in patients with a rare sleep disorder...

US FDA unveils new pathway to approve personalized therapies

US FDA unveils new pathway to approve personalized therapies  The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic...

Amgen cholesterol drug cuts risk of first cardiac event by 25%

Amgen cholesterol drug cuts risk of first cardiac event by 25% Adding Amgen's cholesterol drug Repatha to standard therapy reduced major cardiovascular events by 25%...

What Happens to Your Blood Sugar When You Eat Carrots Regularly

What Happens to Your Blood Sugar When You Eat Carrots Regularly Carrots often get an unfair reputation for their effect on blood sugar levels due...

CRISPR gene-editing works to reduce high cholesterol in a new study

CRISPR gene-editing works to reduce high cholesterol in a new study A single infusion of an experimental gene-editing drug appears safe and effective for cutting...

US FDA to drop black box warnings from menopause hormone therapies

US FDA to drop black box warnings from menopause hormone therapies  The U.S. Food and Drug Administration said on Monday it would remove the strictest...

Novo Nordisk, Emcure to launch weight-loss drug under new brand in...

Novo Nordisk, Emcure to launch weight-loss drug under new brand in India Novo Nordisk launched Wegovy in India in June, three months after Eli Lilly (LLY.N), opens new tab introduced...